Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 15267: Efficacy and Safety of Combination Therapy with GLP-1 and SGLT2 Inhibitors versus GLP-1 Monotherapy in Patients with Type 2 Diabetes and Heart Failure with Preserved Ejection Fraction (HFpEF)

Background: According to the European Society of Cardiology (ESC) guidelines, both GLP-1 receptor agonists and SGLT2 inhibitors have documented cardiovascular benefits in patients with type 2 diabetes mellitus (T2DM), with SGLT2 inhibitors particularly recommended to reduce heart failure hospitalizations. However, r...

Vikash Jaiswal, M. Banach, Akash Jaiswal et al. · 0 citations
Open access Nov 2026

Clinical Outcomes Following GLP-1 Receptor Agonist Initiation With Versus Without Background SGLT2 Inhibitor Therapy in Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes: A Propensity-Matched Real-World Analysis

SGLT2 inhibitors (SGLT2i) improve heart failure outcomes, and GLP-1 receptor agonists (GLP-1 RA) confer cardiometabolic benefit. However, outcomes after GLP-1 RA initiation according to background SGLT2i use remain uncertain. Using TriNetX, we compared GLP-1 RA initiation in patients with HFpEF and type 2 di...

Vikash Jaiswal, M. Banach, Asmita Gera et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.